Press Release Milestone Pharmaceuticals Initiates Pivotal Phase 3 Trial of Etripamil Nasal Spray for Self-Administered Treatment of Atrial Fibrillation with Rapid Ventricular Rate (AFib-RVR) Aug 21
Press Release Milestone Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 12, 2026 Aug 4